Corbus Pharmaceuticals Holdings, Inc. posts $-42.35 million annual loss

Corbus Pharmaceuticals Holdings, Inc. [CRBP]  has posted annual loss of $-42.35 million for the year ended Dec 31,2022.

The company based in Massachusetts(MA)reported a fellin revenue to $0 milion for the year when compared to $0.8817 million in the previous year.

A filing from the company with the Securities and Exchange Commission on Mar 7,2023 showed that its revenue is  up 100.00% year-over-year.

The company reported basic earnings per share of $4170675 and diluted earnings per share of $4170675.

Corbus Pharmaceuticals Holdings, Inc. operates in the Pharmaceutical Preparations sector.